These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7954274)

  • 1. Randomized clinical trials in oncology. Principles and obstacles.
    Simon R
    Cancer; 1994 Nov; 74(9 Suppl):2614-9. PubMed ID: 7954274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Meta-analyses on individual patient data and treatment evaluation in oncology].
    Pignon JP; Aupérin A; Hill C
    Bull Cancer; 2007 Nov; 94(11):957-64. PubMed ID: 18055313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Meta-analyses of randomized trials in oncology: pros and cons].
    Hill C; Pignon JP
    Bull Cancer; 1999 Mar; 86(3):259-64. PubMed ID: 10210759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and analysis of prostate cancer trials.
    Sylvester R
    Acta Urol Belg; 1994 Apr; 62(1):23-9. PubMed ID: 8197926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality-of-life as co-primary endpoint in randomized clinical trials in oncology.
    Fiteni F; Pam A; Anota A; Vernerey D; Paget-Bailly S; Westeel V; Bonnetain F
    Expert Rev Anticancer Ther; 2015; 15(8):885-91. PubMed ID: 26027598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The method of conducting randomized trials in cancerology must be changed].
    Hill C
    Bull Cancer; 2002 Sep; 89(9):823-5. PubMed ID: 12368134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods and design considerations for randomized clinical trials evaluating surgical or endovascular treatments for cerebrovascular diseases.
    Qureshi AI; Hutson AD; Harbaugh RE; Stieg PE; Hopkins LN;
    Neurosurgery; 2004 Feb; 54(2):248-64; discussion 264-7. PubMed ID: 14744272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisiting sample size: are big trials the answer?
    Lurati Buse GA; Botto F; Devereaux PJ
    J Bone Joint Surg Am; 2012 Jul; 94 Suppl 1():75-9. PubMed ID: 22810453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What questions can large, simple trials answer?
    Sandercock P
    Cerebrovasc Dis; 1998 Mar; 8 Suppl 2():30-6. PubMed ID: 9570024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance in pediatric oncology randomized controlled treatment trials: a systematic review.
    Howard AF; Goddard K; Rassekh SR; Samargandi OA; Hasan H
    Trials; 2018 Oct; 19(1):539. PubMed ID: 30290839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analyses of randomised clinical trials in oncology.
    Pignon JP; Hill C
    Lancet Oncol; 2001 Aug; 2(8):475-82. PubMed ID: 11905723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
    Chang LW; Harris J; Humphreys E
    Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical pitfalls in neonatal comparative effectiveness trials.
    Modi N
    Neonatology; 2014; 105(4):350-1. PubMed ID: 24931328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Easily applicable multiple testing procedures to improve the interpretation of clinical trials with composite endpoints.
    Schüler S; Mucha A; Doherty P; Kieser M; Rauch G
    Int J Cardiol; 2014 Jul; 175(1):126-32. PubMed ID: 24861257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interim analyses and stopping rules in cancer clinical trials.
    Whitehead J
    Br J Cancer; 1993 Dec; 68(6):1179-85. PubMed ID: 8260370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Network meta-analyses: Interest and limits in oncology].
    Ribassin-Majed L; Pignon JP; Michiels S; Blanchard P
    Bull Cancer; 2016 Mar; 103(3):289-93. PubMed ID: 26917469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exact permutational tests for group sequential clinical trials.
    Mehta CR; Patel N; Senchaudhuri P; Tsiatis A
    Biometrics; 1994 Dec; 50(4):1042-53. PubMed ID: 7786986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Limitations of meta-analysis from published data in epidemiological research].
    Blettner M; Schlehofer B; Sauerbrei W
    Soz Praventivmed; 1997; 42(2):95-104. PubMed ID: 9221627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical principles for clinical trials.
    Kay R
    J Int Med Res; 1998; 26(2):57-65. PubMed ID: 9602983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.